Stock Track | Genor Biopharma Surges Nearly 88% on Merger Deal with Edding Group

Stock Track10-07

Shares of Hong Kong-listed biotech company Genor Biopharma Holdings Ltd (06998.HK) skyrocketed by 87.88% on Monday, closing at HK$xx.xx per share. The massive surge in stock price comes after the company announced a merger agreement with Edding Group Company on September 13, 2024.

Under the terms of the agreement, Genor Biopharma will acquire Edding Group Company through a share-for-share transaction. The consideration for the proposed merger will be settled entirely through the issuance of new Genor Biopharma shares, known as "consideration shares." Genor Biopharma's subsidiary, GenEdd, will be merged into Edding Group Company as part of the deal.

Analysts suggest that the market has responded positively to the merger news, viewing it as a strategic move for Genor Biopharma to expand its business and product portfolio. Edding Group Company is a well-established player in the pharmaceutical industry, and the combination of the two companies could create synergies and unlock new growth opportunities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

1

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1141696369?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-07 09:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141696369","market":"us","top_or_hot":-1,"title":"Stock Track | Genor Biopharma Surges Nearly 88% on Merger Deal with Edding Group","media":"Stock Track","content":"<p>Shares of Hong Kong-listed biotech company Genor Biopharma Holdings Ltd (06998.HK) skyrocketed by 87.88% on Monday, closing at HK$xx.xx per share. The massive surge in stock price comes after the company announced a merger agreement with Edding Group Company on September 13, 2024.</p>\n\n<p>Under the terms of the agreement, Genor Biopharma will acquire Edding Group Company through a share-for-share transaction. The consideration for the proposed merger will be settled entirely through the issuance of new Genor Biopharma shares, known as \"consideration shares.\" Genor Biopharma's subsidiary, GenEdd, will be merged into Edding Group Company as part of the deal.</p>\n\n<p>Analysts suggest that the market has responded positively to the merger news, viewing it as a strategic move for Genor Biopharma to expand its business and product portfolio. Edding Group Company is a well-established player in the pharmaceutical industry, and the combination of the two companies could create synergies and unlock new growth opportunities.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Genor Biopharma Surges Nearly 88% on Merger Deal with Edding Group</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Genor Biopharma Surges Nearly 88% on Merger Deal with Edding Group\n</h2>\n\n<h4 class=\"meta\">\n\n2024-10-07 09:30 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Hong Kong-listed biotech company Genor Biopharma Holdings Ltd (06998.HK) skyrocketed by 87.88% on Monday, closing at HK$xx.xx per share. The massive surge in stock price comes after the ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06998","symbol_name":"嘉和生物-B","start_time":0,"source_url":"","article_id":"1141696369","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141696369","pubTimestamp":1728264657,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Hong Kong-listed biotech company Genor Biopharma Holdings Ltd  skyrocketed by 87.88% on Monday, closing at HK$xx.xx per share. The massive surge in stock price comes after the company announced a merger agreement with Edding Group Company on September 13, 2024.Under the terms of the agreement, Genor Biopharma will acquire Edding Group Company through a share-for-share transaction. The consideration for the proposed merger will be settled entirely through the issuance of new Genor Bioph","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06998":"嘉和生物-B"},"translate_title":"嘉和生物制药(Genor Biopharma)与Edding Group合并交易后股价飙升近88%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06998":1},"content_text":"Shares of Hong Kong-listed biotech company Genor Biopharma Holdings Ltd (06998.HK) skyrocketed by 87.88% on Monday, closing at HK$xx.xx per share. The massive surge in stock price comes after the company announced a merger agreement with Edding Group Company on September 13, 2024.\nUnder the terms of the agreement, Genor Biopharma will acquire Edding Group Company through a share-for-share transaction. The consideration for the proposed merger will be settled entirely through the issuance of new Genor Biopharma shares, known as \"consideration shares.\" Genor Biopharma's subsidiary, GenEdd, will be merged into Edding Group Company as part of the deal.\nAnalysts suggest that the market has responded positively to the merger news, viewing it as a strategic move for Genor Biopharma to expand its business and product portfolio. Edding Group Company is a well-established player in the pharmaceutical industry, and the combination of the two companies could create synergies and unlock new growth opportunities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1141696369"}